In 2014, the UK’s bioscience sector hit a financial high, raising £1.2 billion ($1.97 billion) in innovation capital, or equity capital raised by companies with annual revenues less than $500 million. This was an increase of 143% and more than one-third of the £3.9 billion in bioscience innovation capital that Europe raised that year. The […]
Despite indications that the global economy is continuing to slow, the outlook for sales growth within the instrument and lab product industry is positive. In late October, 15 industry executives completed the online IBO Business Climate Survey. The respondents were IBO subscribers and other solicited participants, each representing a unique company or business unit. The […]
The Izmir Biomedicine and Genome Center (iBG), based at Dokuz Eylül University, was launched in Turkey last month. The Center is considered an opportunity to bring hope and prominence to research in the country. Turkey’s current science funding, most of which is allocated to applied research, though increasing, is less than half of the EU’s […]
A survey by Farmaindustria found that Spain’s pharmaceutical industry spent €950 million ($1.06 billion) on R&D in 2014. This rise in investment followed three years of declines related to the economic crisis. Intramural research accounted for €568 million, or 59% of expenditures, while the remaining investment of €382 million was put toward research contracts with […]
This month, the main German agency for research funding, the DFG, reported results of the country’s Excellence Initiative. Begun in 2006, the program will spend €4.6 billion ($5 billion) over 11 years to strengthen prestigious German universities. From 2011 to 2013, 45 institutions received more than €1 billion to run graduate programs and establish clusters […]
The European Commission has released information about Horizon 2020’s first 100 calls for proposals, which closed on December 1, 2014. For these calls, 31,115 full, eligible proposals were submitted. Applications from those proposals numbered 123,334 and together requested €80.3 billion ($88.5 billion). Of the proposals, 4,315 were retained for funding, and 3,236 grant agreements were […]
With this month’s approval by the European Council of Ministers and Greece’s parliament of the most recent plan to bail out the country, prospects for Greece’s research budgets are improving. Since the Greek financial crisis began, researchers were dependent on international funds, such as Horizon 2020, to support their projects. Now, some money from the […]
Susteren, Netherlands 7/13/15—Research reagent firm Nordic-MUbio has acquired the antibody and protein assets of US-based Brighter Ideas for an undisclosed amount. The acquisition includes the only source of antibodies against native Aequorea victoria green fluorescent protein (GFP). “Citations of GFP remain at a very high level since it was first described in 1994 as it […]
Central European countries spend less than 1% of GDP on R&D, besides Slovenia, which spends 2.6%. But a survey of 411 firms from 11 Central European countries (Bulgaria, Croatia, the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Slovakia and Slovenia) revealed that companies in the region as a whole plan to increase their short- […]
An assessment of 265 biopharmaceutical facilities in the 35 countries comprising the Europe, the Middle East and Africa (EMEA) region found that the combined production of the sites in 2014 was more than 2.4 million L. Among the sites, 26%, 18%, 15% manufactured recombinant proteins only, vaccines only, or “other” (excluding mAbs and blood processing), […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
